Carter Bankshares (CARE) Earnings Analysis
Carter Bankshares (CARE) next reports earnings on 2026-10-22, consensus EPS 0.52 USD. Last quarter (2026-07-23) it missed with EPS 0.53 USD vs 1.44 USD est (-63.2%). It has beaten estimates in 5/8 recent quarters (63%). Trailing P/E 6.68.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CARE next report earnings?
| Next earnings date | 2026-10-22 |
|---|---|
| Consensus EPS estimate | 0.52 USD |
| Revenue estimate | 0.05B |
CARE earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-07-23 | 0.53 USD | 1.44 USD | -63.2% | Miss |
| 2026-04-23 | 0.4 USD | 3.91 USD | -89.8% | Miss |
| 2026-01-29 | 0.41 USD | 0.33 USD | +24.2% | Beat |
| 2025-10-23 | 0.26 USD | 0.39 USD | -33.3% | Miss |
| 2025-07-24 | 0.41 USD | 0.31 USD | +32.3% | Beat |
| 2025-04-24 | 0.32 USD | 0.3 USD | +6.7% | Beat |
| 2025-01-23 | 0.37 USD | 0.21 USD | +76.2% | Beat |
| 2024-10-24 | 0.24 USD | 0.22 USD | +9.1% | Beat |
Beat rate: 5/8 (63%) over reported quarters with consensus data.
CARE valuation and analyst view
| Trailing P/E | 6.68 |
|---|---|
| Trailing EPS | 4.951 USD |
| Price / book | 1.42 |
| Dividend yield | 0.30% |
| Market cap | 0.73B |
| Analyst consensus | Hold (0 buy / 5 hold / 0 sell) |
| Avg price target | 28.5 USD |
Related research pages
Frequently asked questions
When is Carter Bankshares (CARE)'s next earnings date?
Carter Bankshares is next scheduled to report on 2026-10-22, with a consensus EPS estimate of 0.52 USD and revenue estimate of 0.05B.
Did CARE beat earnings last quarter?
In its 2026-07-23 report, CARE posted EPS of 0.53 USD versus a 1.44 USD estimate — a miss of 63.2%.
What is CARE's earnings track record?
Over the last 8 reported quarters with consensus data, CARE beat estimates 5 times (63%).
What is CARE's current P/E ratio and EPS?
CARE trades at a trailing P/E of 6.68 on trailing EPS of 4.951081940895893 USD.
What do analysts rate CARE?
Analyst consensus is "Hold" across 5 ratings (0 strong buy, 0 buy, 5 hold, 0 sell, 0 strong sell). Average 12-month price target: 28.5 USD.